Successful treatment of psoriasis-associated uveitis with ixekizumab after failure of secukinumab and risankizumab

Singapore Med J. 2024 Jan 2. doi: 10.4103/singaporemedj.SMJ-2023-133. Online ahead of print.
No abstract available